New marker for early diagnosis of Alzheimer’s disease
Research News
|
Oct 19, 2023
An international, multicenter study led by Professor Jintai Yu, a researcher at the Tianqiao and Chrissy Chen Institute and a professor of neurology at Fudan University-affiliated Huashan Hospital, has found that increased volume of the sublateral ventricles is a genetic imaging marker of Alzheimer’s disease, and can be used to predict the risk of Alzheimer’s disease at an early stage, independent of traditional imaging markers such as hippocampal volume. The study was recently published in the journal Nature.
“Alzheimer’s disease is a preventable and treatable type of dementia, and sublateral ventricular volume is an extremely easy imaging marker to assess,” Yu said. The results of the study are expected to assist clinicians in the early identification of patients at risk for Alzheimer’s disease and early intervention to improve their quality of life.”
An international, multicenter study led by Professor Jintai Yu, a researcher at the Tianqiao and Chrissy Chen Institute and a professor of neurology at Fudan University-affiliated Huashan Hospital, has found that increased volume of the sublateral ventricles is a genetic imaging marker of Alzheimer’s disease, and can be used to predict the risk of Alzheimer’s disease at an early stage, independent of traditional imaging markers such as hippocampal volume. The study was recently published in the journal Nature.
“Alzheimer’s disease is a preventable and treatable type of dementia, and sublateral ventricular volume is an extremely easy imaging marker to assess,” Yu said. The results of the study are expected to assist clinicians in the early identification of patients at risk for Alzheimer’s disease and early intervention to improve their quality of life.”
